Evidence map›Paper›PMID 36854775›Full record

ArticleExperimental & molecular medicine2023

TGFBI remodels adipose metabolism by regulating the Notch-1 signaling pathway.

Seul Gi Lee, Jongbeom Chae, Seon Min Woo, Seung Un Seo, Ha-Jeong Kim, Sang-Yeob Kim, David D Schlaepfer, In-San Kim, Hee-Sae Park, Taeg Kyu Kwon and 1 more

Open access · goldAbstract read
In one paragraph

Article in Experimental & molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. MicroRNA-21 is a potential therapeutic agent targetingMolecular therapy. Nucleic acids · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Seul Gi LeeDepartment of Food Science and Biotechnology, Kyungpook National University, Daegu, 41566, Republic of Korea.
Jongbeom ChaeDepartment of Food Science and Biotechnology, Kyungpook National University, Daegu, 41566, Republic of Korea.
Seon Min WooDepartment of Immunology, School of Medicine, Keimyung University, Daegu, 42601, Republic of Korea.
Seung Un SeoDepartment of Immunology, School of Medicine, Keimyung University, Daegu, 42601, Republic of Korea.
Ha-Jeong KimDepartment of Physiology, School of Medicine, Kyungpook National University, Daegu, 41944, Republic of Korea.
Sang-Yeob KimASAN Institute for Life Sciences, ASAN Medical Center, Seoul, 05505, Republic of Korea.
David D SchlaepferMoores Cancer Center, University of California, San Diego, La Jolla, CA, 92093, USA.
In-San KimKU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, 02841, Republic of Korea.
Hee-Sae ParkSchool of Biological Sciences and Technology, Chonnam National University, Gwangju, 61186, Republic of Korea.
Taeg Kyu KwonDepartment of Immunology, School of Medicine, Keimyung University, Daegu, 42601, Republic of Korea. kwontk@dsmc.or.kr.
Ju-Ock NamDepartment of Food Science and Biotechnology, Kyungpook National University, Daegu, 41566, Republic of Korea. namjo@knu.ac.kr.
Kyungpook National University · KRKeimyung University · KRAsan Medical Center · KRChonnam National University · KRKorea University · KRUniversity of California San Diego · US

Funding

Dissecting FAK-regulated oncogenic signaling programs in ovarian cancerR01CA247562 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHLAEPFER, DAVID D, STUPACK, DWAYNE G. · 2020 to 2024
$2.3M
Reprogramming the Tumor Microenvironment in Ovarian CancerR01CA254342 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHLAEPFER, DAVID D · 2020 to 2024
$2.1M
NCI NIH HHS R01 CA247562NCI NIH HHS R01 CA254342
6 · The paper itself

Abstract

Extracellular matrix proteins are associated with metabolically healthy adipose tissue and regulate inflammation, fibrosis, angiogenesis, and subsequent metabolic deterioration. In this study, we demonstrated that transforming growth factor-beta (TGFBI), an extracellular matrix (ECM) component, plays an important role in adipose metabolism and browning during high-fat diet-induced obesity. TGFBI KO mice were resistant to adipose tissue hypertrophy, liver steatosis, and insulin resistance. Furthermore, adipose tissue from TGFBI KO mice contained a large population of CD11b

Indexed as

Insulin ResistanceTransforming Growth Factor betaAdipocytesAdipose TissueAdipose Tissue, WhiteAnimalsDiet, High-FatMiceMice, Inbred C57BLObesitySignal TransductionTransforming Growth Factor beta

Identifiers

PMID36854775
PMCPMC10073093
OpenAlexW4322621613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.